Satsuma Pharmaceuticals announces $US300m of funding for R&D in Australia
The pharmaceuticals giant Satsumas Australian subsidiary, has announced a $US100 million grant to research and develop new drugs for cancer, epilepsy and Alzheimer’s disease, with an aim to generate more than $US400 million by 2020.The $US200 million grant will go towards creating new drugs with an effective cancer cure or a new class of drugs…